Johnson & Johnson to Invest $2B in North Carolina Plant, Boost Economy and Jobs

Johnson & Johnson's $2 billion investment in a biologics manufacturing plant in Wilson, North Carolina, signifies a strategic move to enhance its production capabilities in cancer, immunology, and neuroscience portfolios[1]. This facility, expected to begin construction in the first half of 2025, will create 420 jobs and contribute significantly to the local economy by an estimated $2.3 billion over the duration of a 12-year reimbursement grant[2]. The investment aligns with J&J's goal of achieving a 5% to 7% compound annual growth rate between 2025 and 2030 and is part of broader efforts to strengthen its supply chain resilience amid market challenges[1][2].